IMAC Holdings (Nasdaq:BACK) - Aandelenkoers, Nieuws & Analyse

BACK Overzicht aandelen

IMAC Holdings, Inc. heeft geen significante activiteiten. Meer informatie

BACK fundamentele analyse
Sneeuwvlok Score
Waardering	0/6
Toekomstige groei	0/6
Prestaties in het verleden	0/6
Financiële gezondheid	3/6
Dividenden	0/6

Risicoanalyse

Heeft geen betekenisvolle marktkapitalisatie ( $2M )

Heeft een omzet van minder dan 1 miljoen USD ( $0 )

Aandeelhouders zijn het afgelopen jaar substantieel verwaterd

Negatief eigen vermogen

+ 2 meer risico's

IMAC Holdings, Inc. Concurrenten

SunLink Health Systems

NYSEAM:SSY

US$5.4m

Oncology Institute

NasdaqCM:TOI

US$11.6m

U.S. NeuroSurgical Holdings

OTCPK:USNU

US$20.9m

Inspire Veterinary Partners

NasdaqCM:IVP

US$6.2m

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor IMAC Holdings
Historische aandelenkoersen
Huidige aandelenkoers	US$1.08
52 Week Hoogtepunt	US$7.75
52 Week Laag	US$0.98
Bèta	0.26
11 maand verandering	-14.96%
3 maanden verandering	-37.21%
1 Jaar Verandering	-30.32%
33 jaar verandering	-97.25%
5 jaar verandering	-98.17%
Verandering sinds IPO	-99.02%

Recent nieuws en updates

Recent updates

IMAC Holdings, Inc.'s (NASDAQ:BACK) Business And Shares Still Trailing The Industry

Apr 18

Is IMAC Holdings (NASDAQ:IMAC) Using Debt In A Risky Way?

Oct 12

IMAC expands Florida presence with Fort Pierce Chiropractic acquisition for undisclosed amount

Jun 14

We Think IMAC Holdings (NASDAQ:IMAC) Has A Fair Chunk Of Debt

Mar 06

Rendement voor aandeelhouders

	BACK	US Healthcare	US Markt
7D	5.9%	1.6%	2.2%
1Y	-30.3%	2.1%	31.6%

Rendement versus industrie: BACK presteerde slechter dan de US Healthcare -sector, die het afgelopen jaar een rendement van 2.1 % opleverde.

Rendement versus markt: BACK presteerde slechter dan US Market, dat het afgelopen jaar een rendement van 31.6 % opleverde.

Prijsvolatiliteit

Is BACK's price volatile compared to industry and market?
BACK volatility
BACK Average Weekly Movement	11.6%
Healthcare Industry Average Movement	6.8%
Market Average Movement	6.3%
10% most volatile stocks in US Market	15.7%
10% least volatile stocks in US Market	3.1%

Stabiele aandelenkoers: De aandelenkoers van BACK is de afgelopen 3 maanden volatiel geweest.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit van BACK is het afgelopen jaar gedaald van 24% naar 12%, maar is nog steeds hoger dan 75% van de US -aandelen.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
2000	3	Faith Zaslavsky	www.imacholdings.com

IMAC Holdings, Inc. heeft geen significante activiteiten. Voorheen bezat en beheerde het innovatieve medische vooruitgang en zorgvernieuwingscentra en backspaceklinieken. Het bedrijf is opgericht in 2000 en heeft zijn hoofdkantoor in Brentwood, Tennessee.

IMAC Holdings, Inc. Samenvatting

Hoe verhouden de winst en inkomsten van IMAC Holdings zich tot de beurswaarde?
BACK fundamentele statistieken
Marktkapitalisatie	US$1.86m
Inkomsten(TTM)	-US$5.63m
Inkomsten(TTM)	n/a

0.0x

P/S-verhouding

-0.3x

Koers/Winstverhouding

Is BACK overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
BACK resultatenrekening (TTM)
Inkomsten	US$0
Kosten van inkomsten	US$860.77k
Brutowinst	-US$860.77k
Overige uitgaven	US$4.77m
Inkomsten	-US$5.63m

Laatst gerapporteerde inkomsten

Mar 31, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	-3.27
Brutomarge	0.00%
Nettowinstmarge	0.00%
Schuld/Eigen Vermogen Verhouding	0%

Hoe presteerde BACK op de lange termijn?

Bekijk historische prestaties en vergelijking

BACK Overzicht aandelen

Risicoanalyse

IMAC Holdings, Inc. Concurrenten

NYSEAM:SSY

US$5.4m

NasdaqCM:TOI

US$11.6m

OTCPK:USNU

US$20.9m

NasdaqCM:IVP

US$6.2m

Prijsgeschiedenis en prestaties

Recent nieuws en updates

IMAC Holdings Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10 Q

IMAC Holdings, Inc. announced delayed 10-Q filing

IMAC Holdings, Inc. announced that it expects to receive $3.74 million in funding from a group of investors

Imac Holdings Inc. Announces the Launch of an Entirely New Precision Oncology Assay for Breast Cancer Treatment Decision Making Utilizing the Reverse Phase Protein Array (Rppa) Technology Through Its Newly Established Subsidiary, Ignite Proteomics Llc

IMAC Holdings, Inc. Announces Resignation of Cary Sucoff as Director

IMAC Holdings, Inc. announced delayed 10-Q filing

Recent updates

IMAC Holdings Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10 Q

IMAC Holdings, Inc. announced delayed 10-Q filing

IMAC Holdings, Inc. announced that it expects to receive $3.74 million in funding from a group of investors

Imac Holdings Inc. Announces the Launch of an Entirely New Precision Oncology Assay for Breast Cancer Treatment Decision Making Utilizing the Reverse Phase Protein Array (Rppa) Technology Through Its Newly Established Subsidiary, Ignite Proteomics Llc

IMAC Holdings, Inc. Announces Resignation of Cary Sucoff as Director

IMAC Holdings, Inc. announced delayed 10-Q filing

IMAC Holdings, Inc. announced that it has received $1 million in funding

IMAC Holdings, Inc. has filed a Follow-on Equity Offering in the amount of $10 million.

IMAC Holdings, Inc. Announces Chief Executive Officer Changes

IMAC Holdings, Inc. Announces Board Resignations

Theralink Technologies, Inc. (OTCPK:THER) cancelled the acquisition of IMAC Holdings, Inc. (NasdaqCM:BACK) in a reverse merger transaction.

IMAC Holdings, Inc. announced delayed annual 10-K filing

Insufficient new directors

IMAC Holdings, Inc. Announces Executive Changes

IMAC Holdings Receives Letter from Nasdaq Regarding Non-Compliance with the Minimum Stockholders’ Equity Requirement of $2.5 Million for Continued Listing on the Nasdaq Capital Market Under Listing Rule 5550(b)(1)

IMAC Holdings, Inc. announced delayed 10-Q filing

Insufficient new directors

IMAC Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements

IMAC Holdings, Inc. Receive Non-Compliance Letter from Nasdaq

IMAC Holdings, Inc. Announces 1-for-30 Reverse Stock Split to Regain Compliance

Price target decreased by 17% to US$1.25

IMAC Holdings Provides Nasdaq Compliance Update Regarding Minimum Stockholders' Equity Requirement and Minimum Bid Price Requirement

IMAC Holdings, Inc. announced that it has received $4.3 million in funding from Theralink Technologies, Inc. and other investors

IMAC Holdings, Inc., Annual General Meeting, Jul 05, 2023

IMAC Holdings Receives A Non-Compliance Letter from the Listing Qualifications Department of the Nasdaq Stock Market

Theralink Technologies, Inc. (OTCPK:THER) entered into a definitive agreement and plan of merger to acquire IMAC Holdings, Inc. (NasdaqCM:BACK) in a reverse merger transaction.

IMAC Holdings, Inc. announced delayed 10-Q filing

IMAC Holdings, Inc.'s (NASDAQ:BACK) Business And Shares Still Trailing The Industry

Consensus forecasts updated

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased to US$5.00

IMAC Holdings, Inc. Launches E-Commerce Website for Vitamin and Supplement Line

IMAC Holdings Receives Notice from The Nasdaq Stock Market Regarding Minimum Bid Price Requirement

IMAC Holdings, Inc. Announces Completion of Third Cohort of Its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson's Disease

Consensus estimates of losses per share improve by 10%

IMAC Holdings, Inc. Announces Addition of Medical Weight Loss Services to IMAC Regeneration Centers

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

IMAC Holdings, Inc. has completed a Follow-on Equity Offering in the amount of $3.925 million.

IMAC Holdings, Inc. Adds Stretch Services At the Backspace

Price target decreased to US$5.50

IMAC Holdings, Inc. Announces the Launch of Spinal Health and Wellness Products and Supplements

IMAC Holdings, Inc., Annual General Meeting, Jul 06, 2022

IMAC Holdings, Inc. announced delayed annual 10-K filing

IMAC Holdings, Inc. Announces Completion of Second Cohort of Its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’S Disease

IMAC Holdings, Inc. Announces Executive Changes

Imac Holdings, Inc. Announces Relocates of Growing Clinic in St. Louis Area

Third quarter 2021 earnings released: US$0.068 loss per share (vs US$0.12 loss in 3Q 2020)

Is IMAC Holdings (NASDAQ:IMAC) Using Debt In A Risky Way?

Consensus EPS estimates fall to -US$0.38

Price target decreased to US$3.50

Second quarter 2021 earnings released: US$0.15 loss per share (vs US$0.20 loss in 2Q 2020)

IMAC Holdings, Inc. Announces Initiation of Second Cohort of Its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease

IMAC Holdings Launches Acute Care Services for Musculoskeletal Injuries

IMAC Holdings, Inc. (NasdaqCM:IMAC) agreed to acquire Active Medical Center Ltd.

IMAC Holdings, Inc. (NasdaqCM:IMAC) acquired Fort Pierce Chiropractic.

IMAC expands Florida presence with Fort Pierce Chiropractic acquisition for undisclosed amount

Imac Holdings, Inc. Introduces the Back Space - First In-Store Chiropractic and Spinal Care Location Within Walmart

Consensus EPS estimates increase to -US$0.34

Consensus revenue estimates fall to US$14.3m

First quarter 2021 earnings released: US$0.15 loss per share (vs US$0.18 loss in 1Q 2020)